Table of Contents

Section 1 DEMOGRAPHICS

1 Demographics, Allan Collins

Section 2 VASCULAR ACCESS FOR HEMODIALYSIS

2 Temporary Vascular Access for Hemodialysis, John J. White, Matthew J. Oliver, and Steve J. Schwab
3 Evaluation for Vascular Access Dysfunction, David Windus
4 Vascular Access for Hemodialysis, Peter F. Lawrence
5 Major Complications from Vascular Access for Chronic Hemodialysis, Jeffrey L. Kaufman
6 Dialysis Access Recirculation, Richard A. Sherman and Toros Kapoian

Section 3 PERITONEAL ACCESS DEVICES

7 Peritoneal Access Devices and Placement Techniques, Stephen R. Ash
8 Complications of Acute Peritoneal Catheter Insertion, Anthony R. Zappacosta

Section 4 MECHANICAL ASPECTS OF DIALYSIS

9 Water Treatment Equipment for In-Center Hemodialysis: Including Verification of Water Quality and Disinfection, Richard A. Ward
10 Single-Patient Hemodialysis Machines, Richard A. Ward
11 Single Needle Dialysis, Matthias Kraemer
12 Safety Monitors in Hemodialysis, Joanne D. Pittard
13 Methods of Hemodialysis Anticoagulation, Patrick H. Pun and Eugene C. Kovalik
14 Home Preparation and Installation for Home Hemodialysis, Christopher R. Blagg and Connie Anderson
15 Peritoneal Dialysis Cyclers and other Mechanical Devices, Jose A. Diaz-Buxo

Section 5 DIALYZERS

16 Choosing the Dialyser Technical and Clinical Considerations, Nicholas A. Hoenich and Claudio Ronco
17 Biocompatibility of Dialysis Membranes, Nicholas A Hoenich and Claudio Ronco

Section 6 KINETIC MODELING IN HEMODIALYSIS

18 Urea Kinetic Modeling to Guide Hemodialysis Therapy in Adults, Frank A. Gotch
19 Simplified Formulas and Nomograms for Monitoring Hemodialysis Adequacy, Richard A. Sherman and Robert Hootkins

Section 7 IMPROVING OUTCOMES IN DIALYSIS PATIENTS

20 Quality, Safety, and

Details

No. of pages:
1632
Language:
English
Copyright:
© 2007
Published:
Imprint:
Saunders
Electronic ISBN:
9781437711103
Print ISBN:
9781416041979

About the authors

Richard Fine

Dr. Richard E. Fine received his Bachelor’s and Ph.D degrees in Biochemistry from University of California at Berkeley and Brandeis University respectively. He then was a postdoctoral fellow in the laboratory of Francis Crick and Sydney Brenner at the Laboratory of Molecular Biology in Cambridge, U.K. During this period he and his colleague, Dennis Bray provided the first evidence for actin in growing neurons. Dr. Fine became an Assistant Professor of Physiology and Biochemistry at Boston University School of Medicine and demonstrated the existence of actin regulatory molecules, tropomyosin and troponin C in growing neurons, and he subsequently became interested in the role of clathrin coated vesicles in endocytic and exocytic processes in neurons and in other tissues. He also isolated and characterized vasopressin receptors, demonstrated for the first time that a large molecular, transferrin, can cross the blood brain barrier. His laboratory used an antisense oligonucleotide for the first time in vivo in the rabbit retina to demonstrate the critical role of kinesin in the transport of synaptic vesicles, neuropeptide containing vesicles and vesicles destined for the plasma membrane. In recent years Dr. Fine’s laboratory has focused on the role of the amyloid beta peptide in Alzheimer’s disease especially in brain capillary endothelium. Also he has recently focused on the role of a mutant protein VPS35, a component of the retromer in Parkinson’s and Alzheimer’s diseases. During his career he has received over $25,000,000 in grant funding, have served on both NIH and VA review panels and authored or co-authored over 100 research papers.